[U.S. Food and Drug Administration]

FDA Medical Bulletin * Summer 1998 * Volume 28 Number 1

Future Teleconference

Neonatal/Pediatric HIV Infection

The Department of Health and Human Services is pleased to announce a 2-hour satellite downlink video program to examine issues related to perinatal transmission of HIV, and the "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection" The 2-hour live broadcast is scheduled to air July 22, 1998 from 1:00 P.M. to 3:00 P.M. (EDT). This series is a joint effort of the Health Resources and Services Administration, the National Institutes of Health, the Food and Drug Administration, the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Services Administration, the Health Care Financing Administration, and the Indian Health Service.

Participation is free. Health care providers, patients, and other interested persons are encouraged to view this program. Locations for this program will be posted at http://www.tech-res-intl.com/hivaids/ as downlink sites register.

The New Jersey AIDS Education and Training Center (NJAETC) will offer CME credits for physicians and CEU credits for nurses for a fee of $10. The Association of Social Workers will offer CEUs for a fee of $10. Information and details will be made available at the same website.

You may view and print the Guidelines from the CDC AIDS Clearinghouse website at http://www.cdcnpin.org and at the AIDS Treatment Information Service (ATIS) website at http://www.hivatis.org. You may also obtain a copy of the Guidelines by calling the AIDS Clearinghouse at 1-800-458-5231.

A videotape is available from a program originally broadcast on February 27, 1998, "Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents".

Please e-mail sleeney@tech-res.com to obtain further information on this videotape. To obtain a copy of this videotape send a check for $12.00 to:

Technical Resources International, Inc.
Attn: Sharon Leeney
3202 Tower Oaks Blvd.
Rockville, MD 20852

REPORT SERIOUS ADVERSE EVENTS AND PRODUCT PROBLEMS TO MEDWATCH
1-800-FDA-1088

Table of Contents | FDA Home Page